Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Contact Us

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Glenmark Pharmaceuticals Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	532296
ISIN Demat	INE935A01035
Book Value	879.93

NSE Code	GLENMARK
Dividend Yield %	0.12
Market Cap	579499.36

P/E	38.98
EPS	52.69
Face Value	1


	BSE		NSE

05-Sep-2025

Last Price	2053.50
Net Change	62.9
% Change	3.16%
Prev.Close	1990.60
Open	1990.60
High	2056.35
Low	1990.60
Volume	18367

Last Price	2051.90
Net Change	61
% Change	3.06%
Prev.Close	1990.90
Open	1990.90
High	2055.20
Low	1990.90
Volume	977419

Value	37545016
Best Buy	0.00
Best Sell	0.00
Best Quantity	0
Sell Quantity	0
Today's Range	2056.35
52-Week High	2286.15
52-Week Low	1274.70

Value	1997370688
Best Buy	2051.90
Best Sell	0.00
Best Quantity	88
Sell Quantity	0
Today's Range	2055.20
52-Week High	2284.80
52-Week Low	1275.50

Open Price	2000.00
High Price	2062.00
Low Price	2000.00
Last Price	2057.80
Prev Close	1997.90
Change	59.90
% Change	3.00 %

Average Price	2047.22
Underlying Value	2051.90
Number of contracts traded	5864
Turnover in Rs. Lakhs	45018
Open Interest	7708125.00
Change in O I	192750.00
% Change in O I	2.56 %

Today

|

1W

|

1M

|

1Y

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	88
Price	2051.90

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	375
Price	2060.1

Quantity	1500
Price	2061.9

Holding Details

Latest Corporate Events

Bonus

1 : 1

04-Mar-05

Book Closure

17-Sep-24

27-Sep-24

Dividend

250 %

15-Sep-25

Company News

05-09-2025

Glenmark Pharmaceuticals ...

05-09-2025

Glenmark Pharmaceuticals ...

02-09-2025

Glenmark Pharmaceuticals’...

02-09-2025

Glenmark Pharmaceuticals ...

21-08-2025

Glenmark Pharma makes rem...

21-08-2025

Glenmark Pharma gains on ...

19-08-2025

Glenmark Pharmaceuticals ...

Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores

Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.